Compare Oriental Aromat. with Similar Stocks
Dashboard
Weak Long Term Fundamental Strength with a -15.52% CAGR growth in Operating Profits over the last 5 years
- The company has been able to generate a Return on Equity (avg) of 5.75% signifying low profitability per unit of shareholders funds
The company has declared negative results for the last 3 consecutive quarters
Despite the size of the company, domestic mutual funds hold only 0% of the company
Stock DNA
Specialty Chemicals
INR 976 Cr (Micro Cap)
99.00
39
0.17%
0.60
1.48%
1.46
Total Returns (Price + Dividend) 
Latest dividend: 0.5 per share ex-dividend date: Aug-08-2025
Risk Adjusted Returns v/s 
Returns Beta
News
When is the next results date for Oriental Aromatics Ltd?
The next results date for Oriental Aromatics Ltd is scheduled for 12 February 2026....
Read full news article
Oriental Aromatics Ltd Technical Momentum Shifts Amid Bearish Sentiment
Oriental Aromatics Ltd has experienced a subtle shift in its technical momentum, moving from a strongly bearish stance to a mildly bearish trend, despite a recent uptick in price. This nuanced change comes amid mixed signals from key technical indicators such as MACD, RSI, and moving averages, reflecting ongoing uncertainty in the specialty chemicals sector.
Read full news article
Oriental Aromatics Ltd is Rated Strong Sell
Oriental Aromatics Ltd is rated Strong Sell by MarketsMOJO. This rating was last updated on 11 Nov 2025, reflecting a shift from the previous 'Sell' grade. However, the analysis and financial metrics discussed below represent the stock's current position as of 03 February 2026, providing investors with an up-to-date view of the company’s performance and outlook.
Read full news article Announcements 
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
06-Feb-2026 | Source : BSEIntimation of conference call under the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 to discuss the Financial Performance of the Company for the quarter and nine months ended 31st December 2025.
Board Meeting Intimation for Consideration Of Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended 31St December 2025
05-Feb-2026 | Source : BSEOriental Aromatics Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve the Unaudited Standalone and Consolidated Financial Results for the quarter and nine months ended 31st December 2025;
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018
08-Jan-2026 | Source : BSERe-submission of Certificate under Regulation 74(5) of SEBI (Depositories & Participant) Regulation 2018 for the quarter ended 31st December 2025.
Corporate Actions 
12 Feb 2026
Oriental Aromatics Ltd has declared 10% dividend, ex-date: 08 Aug 25
Oriental Aromatics Ltd has announced 5:10 stock split, ex-date: 13 Dec 18
Oriental Aromatics Ltd has announced 1:1 bonus issue, ex-date: 13 Dec 18
No Rights history available
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Dec 2025
Shareholding Compare (%holding) 
Promoters
None
Held by 0 Schemes
Held by 10 FIIs (0.03%)
Shyamal Anil Bodani (37.08%)
None
19.19%
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
YoY Growth in quarter ended Sep 2025 is 14.60% vs 4.39% in Sep 2024
YoY Growth in quarter ended Sep 2025 is -94.99% vs 510.74% in Sep 2024
Half Yearly Results Snapshot (Consolidated) - Sep'25
Growth in half year ended Sep 2025 is 9.79% vs 7.10% in Sep 2024
Growth in half year ended Sep 2025 is -95.19% vs 811.60% in Sep 2024
Nine Monthly Results Snapshot (Consolidated) - Dec'24
YoY Growth in nine months ended Dec 2024 is 8.90% vs -5.17% in Dec 2023
YoY Growth in nine months ended Dec 2024 is 3,357.43% vs -105.44% in Dec 2023
Annual Results Snapshot (Consolidated) - Mar'25
YoY Growth in year ended Mar 2025 is 10.98% vs -1.49% in Mar 2024
YoY Growth in year ended Mar 2025 is 277.25% vs -53.90% in Mar 2024






